LRRC32 and cancer: Finally, the identification of TME-specific targets (e.g. GARP for activated Tregs) may offer targets that are more universally expressed since the TME composition may be more conserved among cancer types and TME-specific antigens may be less genetically unstable than tumour antigens on cancer cells [63].